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Dear Editor
Nasal nitric oxide (nNO) is currently a recommended screening tool for primary ciliary 
dyskinesia (PCD), a rare disease with chronic sinupulmonary issues. Nasal NO levels are 
significantly lower in PCD compared to healthy controls1, making it an ideal screening test. 
More recent publications suggest nNO can even be used in the diagnosis of PCD when 
paired with a consistent phenotype2. As with any testing method, standard protocols are 
necessary to achieve reliable results. We present an important issue related to nasal NO 
testing methods.
In an article entitled Standardizing Nasal Nitric Oxide Measurement as a Test for Primary 
Ciliary Dyskinesia, Leigh and colleagues present a standard operating procedure (SOP) for 
measuring nasal nitric oxide (nNO) using the Ecophysics CLD 88 SP measuring system 
(Dürnten, Switzerland) and establish a disease specific cut-off of < 77 nL/min, with a 
sensitivity of 0.98 and specificity of >0.999 for detecting PCD1. As part of this standard 
protocol, participants achieve palatal closure by exhaling through their mouth into a 
disposable cardboard resistor or party favor. This results in a steady state nNO sampling with 
a stable plateau value. During the measurement, gas is aspirated at a constant rate through a 
sampling line with a disposable foam olive inserted into one nostril at a time with the other 
nostril open to ambient air. An acceptable maneuver includes a 20 second exhalation with a 
steady NO plateau for 3–10 seconds using the “offline NO test” mode. The device operator 
observes the NO tracing in real-time and chooses an acceptable NO plateau based on set 
criteria. The operator directly measures the plateau value. The average concentration of nNO 
in parts per billion (ppb) is multiplied by the sampling flow rate (typically 0.33 L/min on the 
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Ecophysics CLD 88 SP measuring system) to calculate the nNO production in nanoliters per 
minute (nL/min). Acceptable plateau values must be reproducible, with at least two 
measurements in each nostril within 10% of each other. Though this method uses “offline 
NO test” mode, the sample is collected and analyzed in real-time.
At our center, we perform nNO testing with the Ecophysics CLD 88 SP measuring system 
and the “offline” technique described by Leigh and colleagues. However, Ecophysics has 
recently developed “online” software for nNO testing that is interactive with the test subject 
using an incentive “smiley face” image on the screen to cue exhalation force and duration. 
This software is used with a flow head, versus a cardboard resistor, to provide resistance for 
palatal closure and the Denox 88 NO scrubber to provide NO-free air if needed. Using the 
automated software with this “online” method, the default setting for an acceptable NO 
plateau is 4 seconds with a 10% variance to satisfy the plateau requirements. Once these 
criteria are met, the software automatically stops the test, measures the plateau and moves on 
to the next maneuver.
The ATS/ERS guidelines for measurement of nNO in adults and children outline the 
importance of velum closure and a constant sampling flow rate from the nares3, however do 
not further specify methods. These recommendations simply state “any method that reliably 
closes the velum is acceptable3”. Our objective was to evaluate if the Ecophysics flow head 
and “online” software provided similar nNO results compared to the cardboard resistor and 
“offline” protocol outlined by Leigh and colleagues. We hypothesized there would be no 
significant difference between the two methods as both achieve palatal closure.
IRB approval was obtained and consent signed prior to enrollment. Patients referred to 
Pediatric Pulmonology at Riley Hospital for Children for suspected PCD underwent nNO 
testing using the Eco Physics CLD 88 SP measuring system. Participants performed both 
“online” and “offline” nNO testing maneuvers and completed 3 accurate and reproducible 
measurements in each nare with each method. In the “online” method, the plateau was 
automatically measured by the software. In the “offline” method, the plateau was determined 
manually by the operator. In both modes, participants obtained at least a 3 second plateau, 
and the measurement in ppb was multiplied by the flow rate of 0.33L/min to obtain final 
nNO measurements in nL/min. Clinical data was collected by retrospective chart review. 
Statistical testing was conducted using SPSS Version 24. Nasal NO values were compared 
using Wilcoxon signed-rank test.
Fifty participants completed the two methods, 40% male, median age at testing 12.1 years 
(range 4.1–64.1). The most common presenting symptom was cough (76%), followed by 
nasal congestion (50%), sinusitis (46%) and pneumonia/bronchitis (46%). Of the group, 4 
(8%) had definite PCD by ciliary ultrastructural defect, 6 (12%) had possible PCD (nNO 
<77nL/min and consistent phenotype) and the remaining 40 (80%) were classified as 
undefined/other diagnosis (TABLE I). Spirometric indices were calculated using GLI 
reference equations4. For “online” testing, median nNO was 170.9 nL/min (range 5.7–531.1) 
and for “offline” testing, median nNO was 184.5 nL/min (range 6.2–586.2), p<0.0001.
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The difference between nNO measurements using the “online” nasal NO test mode and flow 
head compared to the “offline” NO test mode and cardboard resistor was statistically 
significant, with the “online” values being lower. The differences in these values may be 
because the “online” software default for an acceptable NO plateau is only 4 seconds with a 
10% variance. Once these criteria are met, the software automatically stops the test. We 
found the “online” acquisition terminates after an average of 8.9 seconds (SD 2.2), which in 
our experience is too short to reach the maximum NO value. In the “offline” method, 
participants exhaled an average of 17.6 seconds (SD 5.7). With the “offline” method, 
participants exhale longer, allowing them to reach a full plateau and approach residual 
volume, which further minimizes dilution of nNO with airflow from the lower airways. Both 
methods use the same sampling flow rate and provide adequate mouth pressure for velum 
closure, and thus are likely not causing the difference we demonstrate.
Clinically, the difference in measured nNO levels with each method is quite important. For 
patients with nNO values near the suggested diagnostic cut-off of 77 nL/min, this difference 
in nNO values could lead to false positive results. Thus, the Genetic Disorders of 
Mucociliary Clearance Consortium (GDMCC) recommends using the “offline” method with 
the cardboard resistor in both adults and children1. Since the disease specific cutoff of 77 
nL/min was also derived using the “offline” nNO measurement method, it seems prudent to 
continue using this methodology until studies validate a similar nNO cutoff value using the 
“online” method. This finding highlights the importance of using a standardized approach 
across centers, especially as more widespread use of nNO is performed for PCD diagnosis.
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TABLE I
Demographics
Demographics n=50
Male 20 (40)
Age at testing (years)† 12.1 (4.1–64.1)
FEV1 % predictedǂ 91.7 (25.6)
FEV1 z-scoreǂ −0.66 (2.1)
†Median (range), ǂMean (SD)
Presenting symptoms (most common findings)
Cough 38 (76)
Daily cough 22 (58)
Nasal congestion 25 (50)
Pneumonia/bronchitis 23 (46)
Sinusitis 23 (46)
Rhinorrhea 17 (34)
Unresponsive asthma 17 (34)
Neonatal respiratory distress 9 (18)
Situs inversus totalis 5 (10)
Nasal ciliary biopsy
Normal ultrastructure 11 (22)
Outer dynein arm defect 2 (4)
Central pair defect 2 (4)
PCD determination
Confirmed PCD 4 (8)
Probable PCD 6 (12)
Other diagnosis/undefined 40 (80)
Values are mean (SD) or median (range) for continuous variables and frequency (%) for categorical variables
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